ANXA5 and lip and oral cavity carcinoma: As expected, the apoptosis inhibitor ZVAD slightly decreased the annexin V-detected apoptosis population (Figure 3) and pancaspase activity (Figure 4) in oral cancer cells, following a low concentration of EANT treatment.